[Daiichi Kogyo Pharmaceutical] Considering Reduction of Investment Unit | May 2026

Overview of Capital Policy

Daiichi Kogyo Pharmaceutical announced at the Board of Directors meeting held on May 13, 2026, that it has resolved to consider reducing its investment unit. This is positioned as one of the measures aimed at expanding the individual investor base and improving stock liquidity. Specific measures and implementation timing are yet to be decided, with plans to continue discussions, including stock splits.

Future Outlook and Impact on Investors

By continuing to consider stock splits and reduction of investment units, the company aims to enhance stock liquidity and broaden its investor base. Although specific measures are undecided, these actions are expected to increase market liquidity and improve the investment environment. Investors should pay attention to these important measures as future developments.